Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 26Pain, Postoperative 17Neoplasms 13Lung Neoplasms 12Brain Neoplasms 12Depression 7Carcinoma, Hepatocellular 7Pain 6Colonic Neoplasms 6Thyroid Neoplasms 5Stomach Neoplasms 5Prostatic Neoplasms 5Leiomyoma 5Head and Neck Neoplasms 5Agnosia 5Ovarian Neoplasms 4Multiple Myeloma 4Delirium 4Colorectal Neoplasms 4Anxiety Disorders 4Supratentorial Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Myofibroma 3Lymphoma 3Hemorrhage 3Fatigue 3Emergence Delirium 3Chronic Pain 3Carcinoma, Non-Small-Cell Lung 3

Interventions

Surgical Procedures, Operative 1Sodium Chloride 1Saline Solution 1Radiotherapy 1Radiomics 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hydrocortisone 1Human Growth Hormone 1Diazoxide 1Dexmedetomidine 1Dexamethasone 1Biomarkers 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pituitary Diseases × Saline Solution × Clear all
NCT02549768 2016-10-12

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Pontificia Universidad Catolica de Chile

Phase 4 Unknown
40 enrolled
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡